In a murine model, intraperitoneal IL-18 injection increased eosinophil recruitment into the airways (92), and intranasal rIL-18 administration also transformed CD274-eosinophils to CD274+ pathogenic eosinophils that were shown to promote mucus hypersecretion and airway obstruction (93). The gene discussed is CD274; the disease is Airway obstruction.